Bennie, I agree. The time for talk, promises and forward

New Post Public Reply Private Reply Replies (0) Message Board
EliteYoda Bennie1012 #9015

Bennie, I agree. The time for talk, promises and forward looking statements is over IMO. Now shareholders need to see actualized and realized corp results. To be fair, not that long ago, at the beginning of the year, this company basically had nothing except the Bionic cig product and a mechanic as the CEO along with a sketchy 504D deal with Fairhills Capital which seems to have only given RFMK a headache with a DTC chill because of Fairhills getting caught by the SEC litigation. Since Mr Allinder has taken control, there were promises of a new VInhaler product, and 2,000 units eventually arrived and were sold in real outlets, quarterly filings and funding were promised and that happened, even though the funding was the type the CEO said is not the type he wants for the company, but it was the only funding available for a non reporting pinky. That led him to use the dilutive funding to wipe the company's debt away and clean up the balance sheet as well as funding a (so far) 10,000 unit order along with paying for a full audit and 10K for which both are still promised. Just by way of judging the track record, I personally feel like the audit, 10K and inventory WILL COME, as promised. Call me a wide-eyed naive muppet but I happen to think shareholder value will be delivered, its just the timing that is frustrating holders right now; we have waited so long. I have been very wrong before, but at least I do not claim to know the future unlike many of the bashers who seem to think they know exactly what the future holds. The stock is basically in the gutter just a few ticks from the par value of the stock, which I know does not mean much, especially with only 1% or so of the float "trading" daily but with a few thousand dollars in the market trading hands to push this up 25% or tank it another 25%, worrying about the stock performance right now is just not a focus IMO. The priority right now is getting that audit, 10K and inventory completed. I think all are in agreement. Who knows when it could happen, I just hope it does happen at some point. It would really be unfortunate for shareholders if it never were to happen after the company has already come so far and made so many steps toward success. Even though long term shareholders often must deal with short term pain in any stock, I think its healthier for the CEO to do what he has done recently and fight the tendency to put out fluff PRs if nothing is really happening, its shakes the weak hands out of the stock and spring loads the stock to some degree IMO. It is better for the CEO to just do what needs to be done and focus on the corp side and just ignore irate bashers and shareholders. When there is actualized developments and news, then PR it, otherwise, just let the market guess as to what is happening. Though from time to time I think its also healthy for shareholders to learn what the status is and what is going on by way of shareholder notices; those CAN consist of forward looking statements and plans. I think for the overall market to take notice of an RFMK PR, the "news" needs to actually be news and not just more plans to make plans for things to come in the future. I happen to think also that perhaps the PR void we have witnessed recently is maybe because there could be much in the 10K which would be revealed about future developments (funding, deals, board members, etc). Its all in the hands of the auditors right now, so I remain hopeful but very concerned as a shareholder as well, not because of the stock performance, which has always been a cruel joke nothing more, but I am concerned about the audit and 10K. Shareholders deserve and need that transparency as soon as possible. The inventory coming finally will be a good catalyst as well but I think the key is the 10K because right now, IMO, RFMK's credibility is utterly destroyed and down in the mud with the stock.

Mr Allinder, where is the 10K????

Difficult to see the future is.

$RFMK

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PenFed Credit Union's Soaring Loan Originations in Q3 2026

Updated Category News Views 52

Staggering Growth in Loan Originations Ever wake up to an unexpected windfall? That's the kind of headline PenFed Credit Union is writing with its $8.8 billion in year-to-date loan originations by the end of September 2026. Up 22% year-over-year, folks. Those numbers don't just happen by accident. That's hitting the nail on the head in the credit union world. Mortgage and...

Continue Reading
AstroRad Vest Makes Spaceflight History at Smithsonian

Updated Category News Views 58

Space Gear Finds a New Home In a move that brings a piece of the cosmos down to Earth, the AstroRad radiation protection vest, used by astronauts aboard the International Space Station (ISS), has landed a spot in the Smithsonian's National Air and Space Museum. It's not just some random hunk of tech; this vest represents a milestone in the annals of space gear — a...

Continue Reading
Cooper's Stock Takes a Beating: What's Behind It?

Updated Category News Views 37

A Shock to the System: Cooper's Rough Patch Not every day you see a stock take a body slam like this! Cooper Companies (NASDAQ: COO) got walloped after revealing some unsavory truths about its Q3 2026 performance. The market didn't just flinch—it reeled. On September 10, 2026, COO shares dove a steep $9.31—around a 14.6% free fall—whacking off over $1.7 billion in...

Continue Reading
Green Methanol: A $20.11B Market by 2032 Excites

Updated Category News Views 16

The Green Methanol Boom Folks, the money's about to get greener—greener methanol, that is. We’re talking about a market that’s set to explode from a humble $3.46 billion in 2026 to a jaw-dropping $20.11 billion by 2032. With a hefty CAGR of 34.1%, it seems like investors might want to buckle up for a bullish ride in this eco-friendly venture. Why Green Methanol?...

Continue Reading
Del Monte Faces Class Action Over Major Data Breach

Updated Category News Views 29

Data Breach Fallout Looms Over Del Monte Here's the scoop on Del Monte Foods facing what looks like a data breach debacle of epic proportions. Ransomware has hit the fan, and now folks are scrambling as Edelson Lechtzin LLP gears up to lay down some serious class action heat. From Cyber Shadows to Court Considerations This storm brewed on February 7, 2026. Del Monte’s...

Continue Reading
Cytrellis Boosts Aesthetics Training With Miami Partnership

Updated Category News Views 35

Cytrellis Partners with University of Miami The announcement from Cytrellis Biosystems is drawing some attention. The company's jumped into a new partnership with the University of Miami School of Nursing and Health Studies, looking to jazz up their Aesthetic Medicine Certificate Program. The kicker here is the introduction of Cytrellis' ellacor® system, a fancy bit of...

Continue Reading
BioArctic's Moves: Lecanemab Data and Leadership Insights

Updated Category News Views 60

BioArctic's Power Play: A Two-Pronged Update Ever feel like biotechnology is just a series of chess moves? BioArctic's recent maneuvers in the life sciences game certainly hint at that. First, they've got data brewing on lecanemab—this ain't small beans, folks, not with Alzheimer's disease in the crosshairs. Then there's their Nomination Committee. It’s like shaking...

Continue Reading
SCI Faces Investigation After Earnings Downgrade

Updated Category News Views 55

SCI's Rough Ride: Investors Brace for Impact There's nothing like waking up to find the stock you were banking on took a nosedive while you were dreaming of dividends. Service Corporation International (NYSE: SCI) sure gave shareholders more of a nightmare than a dream, slashing its earnings forecast for 2026 and watching its stock crumble by about 11.6% on October 29....

Continue Reading
Intestinal Worms: New Science and Old Challenges

Updated Category News Views 43

Intestinal Worms: A Modern Twist on an Old Tale Just when you thought you'd heard it all, here comes the notion that intestinal worms might actually be good for us. The stuff of cringe-worthy junior high biology classes is now strutting its stuff in F1000Research. Sounds odd? Maybe, but there's a half-century of science behind it. Old Foes with New Friends These...

Continue Reading
Gastops and Bell: A New Era in Aerospace Collaboration

Updated Category News Views 17

Gastops and Bell Seal a Forward-Looking Deal Who would've thought Gastops and Bell, two juggernauts in their respective fields, would link arms to drive the aerospace game forward in Canada? That's right, a Memorandum of Understanding (MOU) was inked between these titans at the 2026 Canadian Aerospace Summit, paving the way for collaboration on future programs. This isn't...

Continue Reading

Top 5 Most Recently Viewed Articles

Vitesse Energy's Q3 Performance and Future Prospects Examined

Updated Category News Views 65

Vitesse Energy's Third Quarter Highlights Vitesse Energy, Inc. (NYSE: VTS) recently shared its financial and operating results for the third quarter. The company reported a robust net income of $17.4 million alongside an adjusted net income of $7.6 million. The adjusted EBITDA reached $37.6 million, alongside operational cash flow exceeding $45.7 million, showcasing a...

Continue Reading
Capital One Financial Soars After Impressive Third-Quarter Gains

Updated Category News Views 307

Capital One's Remarkable Q3 Performance Capital One Financial Corp. (NYSE: COF) recently unveiled its third-quarter results, showcasing a strong financial performance that exceeded analysts' expectations. The report highlighted significant increases in both earnings and revenue, making a substantial impact on investor confidence and stock performance. Diving into the Key...

Continue Reading
Recent Developments Boost Travere Therapeutics' Market Outlook

Updated Category News Views 83

Update on Travere Therapeutics On a recent Wednesday, Stifel maintained its Hold rating for Travere Therapeutics (NASDAQ:TVTX) while raising the price target to $13.00 from the previous $10.00. This adjustment is a result of a thorough analysis of the company's recent progress, specifically focusing on their drug candidate, Sparsentan. Significance of the PARASOL Workshop...

Continue Reading
Kahoot! Achieves Gold Certification in Educational Equity

Updated Category News Views 106

Kahoot! Achieves Gold Certification in Educational Equity Kahoot!, the renowned education technology platform, has recently been awarded the prestigious ICEIE Gold certification for its unwavering commitment to equity in education. This recognition emphasizes the company's dedication to ensuring that all learners have access to quality educational tools and resources,...

Continue Reading
Spicewood Mineral Partners Expands Holdings with New Acquisitions

Updated Category News Views 91

Spicewood Mineral Partners Expands Holdings in the Permian Basin Spicewood Mineral Partners, a prominent mineral and energy investment firm based in Dallas, has made exciting updates regarding its latest acquisitions in the Delaware Basin. The company has recently targeted a selection of high-quality "tier 1" mineral assets in the Permian Basin, showcasing a strategic...

Continue Reading